Skip to content

NAC effects on patients with AMI undergoing angioplasty

Evluation of N-acetyl cystein on myocardial perfusion and plasma troponin I and hsCPR levels in patients undergoing primary PCI

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT201301048698N8
Enrollment
100
Registered
2013-01-19
Start date
2012-02-01
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Myocardial Infarction. Acute Myocardial Infarction

Interventions

Intervention 1: Intervention: The patients in Intervention group were adminitered to take 100 mg/kg IV bolus N-acetylcystein and then intracoronary and 10mg/kg/h over 12 hours after percutaneous coron
Prevention
Intervention: The patients in Intervention group were adminitered to take 100 mg/kg IV bolus N-acetylcystein and then intracoronary and 10mg/kg/h over 12 hours after percutaneous coronary intervention
Control: Received Standard treatment as for patients with acute myocardial infarction

Sponsors

Tehran Heart Center, Tehran University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 90 Years

Inclusion criteria

Inclusion criteria: Inclusion Criteria:Myocardial infarction patients who were candidate of primary PCI . Exclusion Criteria:rescue pci; emergency for cardiac bypass ; cardiogenic shock; life expactancy less than 6 months; Age less than 18 years old; Uncontrolled hypertension; Thrombocytopenia; Malformation or aneurysm; sever chronic renal failure; Sever liver failure; treatment with glycoprotein IIb/IIIa inhibitors during PCI ; sensitivity to sulfonamides ; Major surjery; Unsatisfactory to enter to study

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Troponin I. Timepoint: Baseline and after 48 hours. Method of measurement: Elisa Kit.;Hs-CRP. Timepoint: Baseline and after 48 hours. Method of measurement: Elisa Kit.;Myocardial Perfusion. Timepoint: Baseline and after Primary Percutaneous Coronary Intervention. Method of measurement: Myocardial Blush Grage and TIMI flow.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactAzita Hajhossein Talasaz, Mostafa Bahremand

Tehran Heart Center, Tehran University of Medical Sciences

atalasaz@razi.tums.ac.ir, mosaffa52@gmail.com+98 218802960050

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Mar 6, 2026